# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016012
Filing Date
2022-11-02
Accepted
2022-11-02 16:31:01
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | edit-20220930x10q.htm iXBRL | 10-Q | 1591457
2 | EX-31.1 | edit-20220930xex31d1.htm | EX-31.1 | 15590
3 | EX-31.2 | edit-20220930xex31d2.htm | EX-31.2 | 15024
4 | EX-32.1 | edit-20220930xex32d1.htm | EX-32.1 | 10101
| Complete submission text file | 0001558370-22-016012.txt |  | 5608141

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | edit-20220930.xsd | EX-101.SCH | 24349
6 | EX-101.CAL | edit-20220930_cal.xml | EX-101.CAL | 40075
7 | EX-101.DEF | edit-20220930_def.xml | EX-101.DEF | 119562
8 | EX-101.LAB | edit-20220930_lab.xml | EX-101.LAB | 300010
9 | EX-101.PRE | edit-20220930_pre.xml | EX-101.PRE | 207292
45 | EXTRACTED XBRL INSTANCE DOCUMENT | edit-20220930x10q_htm.xml | XML | 1070781

Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 221354611
SIC: 2836 Biological Products, (No Diagnostic Substances)